0001209191-18-035849.txt : 20180605
0001209191-18-035849.hdr.sgml : 20180605
20180605173254
ACCESSION NUMBER: 0001209191-18-035849
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180601
FILED AS OF DATE: 20180605
DATE AS OF CHANGE: 20180605
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SACHS BRUCE I
CENTRAL INDEX KEY: 0001197036
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 18882311
MAIL ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-06-01
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001197036
SACHS BRUCE I
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
0
0
0
Common Stock
2018-06-01
4
A
0
1801
0.00
A
15199
D
Common Stock
2018-06-01
4
D
0
2188
D
13011
D
Stock Option (Right to Buy)
152.74
2018-06-01
4
A
0
3229
0.00
A
2028-05-31
Common Stock
3229
3229
D
Deferred Stock Units
2018-06-01
4
A
0
2188
A
Common Stock
2188
8587.164
D
Restricted stock unit that vests, subject to certain limited exceptions, on the first anniversary of the grant date.
Upon the vesting of restricted stock units granted to Mr. Sachs on June 1, 2017, Mr. Sachs deferred the receipt of 2,188 shares of common stock and received instead 2,188 deferred stock units pursuant to the Company's deferred compensation plan. As a result, Mr. Sachs is reporting the disposition of 2,188 shares of common stock in exchange for an equal number of deferred stock units.
Fully vested.
Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death.
/s/ Omar White, Attorney-in-Fact
2018-06-05